Loading…
AEON Biopharma, Inc. is projected to decline to $0.2543 by 2027, a -14% move from its current price of $0.295. AEON is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.273 | $0.2948 | $0.3185 | -0.05% |
| Aug 6 | $0.2642 | $0.2947 | $0.3286 | -0.11% |
| Aug 7 | $0.2577 | $0.2945 | $0.3366 | -0.16% |
| Aug 8 | $0.2523 | $0.2944 | $0.3435 | -0.22% |
| Aug 9 | $0.2476 | $0.2942 | $0.3496 | -0.27% |
| Aug 10 | $0.2434 | $0.294 | $0.3552 | -0.32% |
| Aug 11 | $0.2396 | $0.2939 | $0.3604 | -0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2396 | $0.2939 | $0.3604 | -0.38% |
| Week 2 | $0.2194 | $0.2928 | $0.3907 | -0.76% |
| Week 3 | $0.2048 | $0.2917 | $0.4153 | -1.13% |
| Week 4 | $0.1932 | $0.2906 | $0.437 | -1.51% |
| Week 5 | $0.1834 | $0.2895 | $0.4569 | -1.88% |
| Week 6 | $0.1749 | $0.2884 | $0.4754 | -2.25% |
| Week 7 | $0.1674 | $0.2873 | $0.4929 | -2.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AEON Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine.
It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
The asset AEON Biopharma, Inc. trades with the symbol AEON in the Healthcare sector. Its current price is $0.293 and its market cap is $12.94M, with a rank of 5007.
A major floor 17.6% below — a decisive break under it would weaken the trend.
The nearest floor, 17.6% below — buyers have tended to step in here.
The nearest ceiling, 150.8% above — a clean break opens room to run.
A major ceiling 293.2% above — clearing it would confirm fresh momentum.
Key AEON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AEON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.261 | Buy | $0.2687 | Buy |
| MA 10 | $0.2668 | Buy | $0.2874 | Buy |
| MA 20 | $0.3678 | Sell | $0.3637 | Sell |
| MA 50 | $0.5824 | Sell | $0.5419 | Sell |
| MA 100 | $0.782 | Sell | $0.7284 | Sell |
| MA 200 | $0.9012 | Sell | $4.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 30.60 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -39.02 | Neutral |
| Williams %R (14) | -56.14 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -2.33 | Sell |
| Bollinger %B (20,2) | 0.38 | Neutral |
| Stochastic %K (14) | 43.86 | Neutral |
| TRIX (15) | -2.92 | Sell |
| Awesome (5,34) | -0.24 | Sell |
| Ultimate (7,14,28) | 50.07 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 0.26 | Buy |
| ADX (14) | 46.51 | Sell |
| ATR (14) | 0.02 | Info |
The near-term technical picture is neutral, with RSI14 at 30. The 50-day moving average sits at $0.5824 and the 200-day moving average at $0.9012. A near-term support level is $0.243 and resistance is at $0.74. The 30-day trading range runs from $0.1762 to $0.4872.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.243 | $0.295 | $0.3359 | 0% | Neutral | |
| $0.1853 | $0.2543 | $0.3771 | -14% | Neutral | |
| $0.2264 | $0.3304 | $0.5228 | +12% | Neutral | |
| $0.229 | $0.3522 | $0.5856 | +19% | Neutral | |
| $0.2453 | $0.3956 | $0.6849 | +34% | Bullish | |
| $0.2307 | $0.389 | $0.6974 | +32% | Bullish | |
| $0.1816 | $0.3193 | $0.5904 | +8% | Neutral | |
| $0.1867 | $0.3421 | $0.6502 | +16% | Neutral | |
| $0.1748 | $0.3331 | $0.6493 | +13% | Neutral | |
| $0.2162 | $0.4283 | $0.8543 | +45% | Bullish | |
| $0.1958 | $0.4352 | $0.9543 | +48% | Bullish | |
| $0.3727 | $0.8282 | $1.90 | +181% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.243 | $0.295 | $0.3378 | +0.00% |
| September 2026 | $0.222 | $0.2699 | $0.3423 | -8.51% |
| October 2026 | $0.2278 | $0.2808 | $0.3634 | +4.03% |
| November 2026 | $0.2141 | $0.2669 | $0.351 | -4.96% |
| December 2026 | $0.1999 | $0.2518 | $0.3359 | -5.65% |
Click any year to see its month-by-month AEON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, AEON is projected to trade between $0.243 and $0.3359, averaging $0.295 — a potential gain of 0% from today's $0.295. Price action looks broadly range-bound.
AEON Biopharma, Inc.'s 2027 outlook centres on $0.2543, within a $0.1853 to $0.3771 range. That is -14% versus the projected 2026 average. That marks a -14% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, AEON could reach as high as $0.5228, with a base case around $0.3304 and support toward $0.2264 — roughly +12% from $0.295. Price action looks broadly range-bound.
Expect AEON to range from $0.229 to $0.5856 through 2029. The $0.3522 average target implies a +19% move from current prices. That is up +7% on the projected 2028 average. A consolidation phase looks the most probable path here.
The AEON price prediction for 2030 points to an average of $0.3956 (low $0.2453, high $0.6849) — a potential gain of +34% on today's $0.295. Momentum favours further upside here.
In 2031, AEON is projected to trade between $0.2307 and $0.6974, averaging $0.389 — a potential gain of +32% from today's $0.295. That is -2% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
AEON Biopharma, Inc.'s 2032 outlook centres on $0.3193, within a $0.1816 to $0.5904 range. That is -18% versus the projected 2031 average. That marks a +8% change versus current levels. Price action looks broadly range-bound.
By 2033, AEON could reach as high as $0.6502, with a base case around $0.3421 and support toward $0.1867 — roughly +16% from $0.295. A consolidation phase looks the most probable path here.
Expect AEON to range from $0.1748 to $0.6493 through 2034. The $0.3331 average target implies a +13% move from current prices. That is -3% versus the projected 2033 average. Price action looks broadly range-bound.
The AEON price prediction for 2035 points to an average of $0.4283 (low $0.2162, high $0.8543) — a potential gain of +45% on today's $0.295. Buyers look set to stay in control over this stretch.
In 2040, AEON is projected to trade between $0.1958 and $0.9543, averaging $0.4352 — a potential gain of +48% from today's $0.295. That is up +2% on the projected 2035 average. Momentum favours further upside here.
AEON Biopharma, Inc.'s 2050 outlook centres on $0.8282, within a $0.3727 to $1.90 range. That is up +90% on the projected 2040 average. That marks a +181% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in AEON today (≈ 3,389.830508 AEON) could be worth
$2,807.48
+$1,807.48 (+181%) by 2050 · US Dollar
Based on the average projected AEON price of $0.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AEONwould be worth at today's price.
$1,000 invested in AEON on Jul 31, 2025 (≈ 1,375.515822 AEON) would be worth
$405.78
-$594.22 (-59.4%) today · 0.41× · US Dollar
Based on a AEON entry price of $0.727 vs. today's $0.295.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.251 | $1,175.3 | +17.5% |
| 1 month ago | $0.711 | $414.91 | -58.5% |
| 3 months ago | $0.89 | $331.46 | -66.9% |
| 6 months ago | $1.16 | $254.31 | -74.6% |
| 1 year ago | $0.727 | $405.78 | -59.4% |
| All time (3.6y) ago | $724.32 | $0.41 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AEON forecast.
Our base-case forecast reaches $0.59 around 2050.
Implied market cap at $0.59: $26.05M
The multi-year forecast shows a path from neutral in 2026 to bullish momentum by 2030 and beyond. In 2026 the avg price is $0.293 with min $0.243 and max $0.3339 (ROI 0%, sentiment NEUTRAL). By 2030 the avg rises to $0.3933 with a max of $0.681 and a min of $0.2438, delivering a 34.2% ROI and a bullish sentiment.
2031 shows an avg of $0.386 and 31.7% ROI (bullish). The forecast also notes a bullish stance in 2035 (avg $0.426, ROI 45.4) and in 2040 (avg $0.4313, ROI 47.2). By 2050 the avg price is $0.8238 with a max of $1.89 and a 181.2% ROI, indicating a strongly bullish long-term outlook.
The max price in 2050 is $1.89 and the forecast assigns bullish sentiment to several later years, though some intermediate years show more modest gains or neutral to mixed signals, underscoring the uncertainty and volatility of the path ahead.
Tap a question to reveal the answer.
In 2030, the forecast shows an avg price of $0.3933, with a min of $0.2438 and a max of $0.681; the ROI is 34.2% and the sentiment is BULLISH.
Near term, the forecast signals NEUTRAL sentiment with a 2026 avg of $0.293 (min $0.243, max $0.3339) and a 2027 forecast showing a negative ROI of -13.6%, indicating uncertainty and that gains are not guaranteed.
yes. The 2050 forecast max is $1.89, which exceeds $1.00.
Current price is $0.293 and market cap is $12.94M.
RSI14 is 30 and sentiment is NEUTRAL. SMA50 is $0.5824 and SMA200 is $0.9012, with support at $0.243 and resistance at $0.74. The 30-day range is $0.1762 to $0.4872 and annualized volatility is 100%.
AEON Biopharma, Inc. Community Discussion
0Share your AEON Biopharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.